- Home
- BBIO vs UGI Comparison
BBIO vs UGI Comparison
Compare BBIO & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- UGI
- Stock Information
- Founded
- BBIO 2015
- UGI 1940
- Country
- BBIO United States
- UGI United States
- Employees
- BBIO N/A
- UGI N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- UGI Natural Gas Distribution
- Sector
- BBIO Health Care
- UGI Utilities
- Exchange
- BBIO Nasdaq
- UGI Nasdaq
- Market Cap
- BBIO 4.9B
- UGI 5.4B
- IPO Year
- BBIO 2019
- UGI N/A
- Fundamental
- Price
- BBIO $23.24
- UGI $24.76
- Analyst Decision
- BBIO Strong Buy
- UGI Hold
- Analyst Count
- BBIO 13
- UGI 2
- Target Price
- BBIO $46.92
- UGI $27.00
- AVG Volume (30 Days)
- BBIO 1.7M
- UGI 1.9M
- Earning Date
- BBIO 11-12-2024
- UGI 11-21-2024
- Dividend Yield
- BBIO N/A
- UGI 6.06%
- EPS Growth
- BBIO N/A
- UGI N/A
- EPS
- BBIO N/A
- UGI 3.14
- Revenue
- BBIO $217,765,000.00
- UGI $7,372,000,000.00
- Revenue This Year
- BBIO $3,690.39
- UGI N/A
- Revenue Next Year
- BBIO N/A
- UGI $10.09
- P/E Ratio
- BBIO N/A
- UGI $7.87
- Revenue Growth
- BBIO 2209.77
- UGI N/A
- 52 Week Low
- BBIO $21.62
- UGI $21.51
- 52 Week High
- BBIO $44.32
- UGI $26.15
- Technical
- Relative Strength Index (RSI)
- BBIO 41.84
- UGI 58.63
- Support Level
- BBIO $21.72
- UGI $23.18
- Resistance Level
- BBIO $27.57
- UGI $24.57
- Average True Range (ATR)
- BBIO 1.42
- UGI 0.47
- MACD
- BBIO -0.23
- UGI 0.11
- Stochastic Oscillator
- BBIO 25.98
- UGI 94.72
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, acoramidis (AG10), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing and UGI Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The UGI Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.